Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.
FEATURED PROJECT

Pre-exposure Prophylaxis (PrEP):
Evolving Strategies for HIV Prevention, Treatment, and Testing
Thursday, March 30, 2017
1:00-2:00 pm ET

HIVEarlyTesting.com

This accredited educational webinar presented by Drs. Cynthia C. Brinson and David W. Rosenthal, will review the development and rationale behind pre-exposure prophylaxis (PrEP), identify potential barriers to HIV screening and initiation of PrEP, evaluate current CDC and HRSA guidelines for HIV testing/screening/analysis, determine the role of rapid point-of-care HIV antigen/antibody testing in prophylaxis and early treatment, and discuss strategies to increase screening, earlier interventions, and greater implementation of PrEP to prevent HIV infection.

There is no charge for the program or certificate, but registration is required for the webinar, access to the slides, and CME assessment.

Planned and developed by Medavera, Inc. and supported by Alere, Inc.

THE MEDICAL NEWS
LONDON (Reuters) - Can society afford modern medicines? It's a question facing governments worldwide and nowhere more so than in Britain, where a new budget test due to take effect on April 1 threatens to throw up another hurdle to patients getting the drugs.... (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's Dupixent for treatment of moderate to severe atopic dermatitis, a product widely seen as the most important future growth driver for the two companies.... WASHINGTON (Reuters) - Republicans in the U.S. House of Representatives are considering a renewed push to pass legislation to repeal and replace Obamacare sometime in the next month, lawmakers and aides said on Tuesday after the collapse of the effort last week.... (Reuters Health) - Kids exposed to high levels of lead decades ago may now be approaching middle age with lower IQs and earning potential than they would have had otherwise, a new study suggests.... (Reuters Health) - Women who have insurance coverage for in vitro fertilization (IVF) may be more likely to have a baby than women who have to pay entirely out-of-pocket for fertility treatments, a U.S. study suggests.... BRASÍLIA (Reuters) - Hong Kong said on Tuesday it has lifted a ban on the import of Brazilian meat, removing one of the last blanket bans by a major importer less than two weeks into a scandal over health standards in the sector.... PHNOM PENH (Reuters) - Cambodia on Tuesday banned the export of breast milk, putting a stop to the business of a U.S.-based company that had been selling the milk in the United States.... BURAO, Somalia (Reuters) - In a makeshift camp beside a disused airfield in the breakaway Somali region of Somaliland, 32-year old Nima Mohamed sits next to an open wood fire, boiling a kettle of black tea.... LONDON (Reuters) - AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.... NEW YORK (Reuters) - The amount that drugmaker Mylan NV avoided paying the U.S. government in Medicaid rebates for its EpiPen emergency allergy treatment since 2007 likely exceeds a proposed $465 million settlement the company announced in October, according to a study by private drug pricing experts published on Monday....